Our Services
Medical Information
Helpful Resources
Published on: 2/10/2026
Early signs in women 65+ can include persistent fatigue and unexplained weight loss. Also watch for shortness of breath, leg or ankle swelling, irregular heartbeat, foamy urine or puffiness around the eyes, numbness or tingling or new carpal tunnel in both hands, digestive changes, easy bruising, or an enlarged tongue, especially when several occur together. There are several factors to consider, and early evaluation can protect the heart, kidneys, and nerves; see below for the full list of red flags, what makes amyloidosis easy to miss, how it is diagnosed, when to seek urgent care, and practical next steps to take with your doctor.
Amyloidosis is a rare but serious condition that most often affects adults over 60. For women aged 65 and older, it can be especially difficult to recognize early because its first symptoms often look like normal aging or common chronic conditions. Understanding Amyloidosis, knowing the early warning signs, and acting promptly can make a meaningful difference in outcomes.
This guide explains Amyloidosis in clear, practical language, focusing on what older women and their families should know—without unnecessary alarm, but with honesty about why attention matters.
Amyloidosis is a disease in which abnormal proteins, called amyloid, build up in tissues and organs. Over time, these protein deposits interfere with how organs work. Amyloidosis can affect one organ or several at the same time.
Organs commonly involved include:
There are different types of Amyloidosis, but the most common in older adults include:
Age-related ATTR Amyloidosis, sometimes called "wild-type," is increasingly recognized in adults over 65 and may be underdiagnosed in women.
Amyloidosis is often called a "master of disguise." Many early symptoms overlap with common conditions such as arthritis, heart disease, diabetes, or simple aging. Women may also experience:
Because of this, Amyloidosis is frequently diagnosed later than ideal—when organ damage is more advanced.
Not everyone experiences the same symptoms, but patterns matter. The following signs are worth discussing with a healthcare provider, especially if they appear together or worsen over time.
These symptoms are common in many conditions, but persistent or unexplained changes deserve attention.
Amyloidosis affecting the heart (cardiac Amyloidosis) is increasingly recognized in women over 65.
Watch for:
These symptoms are often mistaken for heart failure or aging-related heart changes, but Amyloidosis may be an underlying cause.
Kidney involvement is common in Amyloidosis.
Possible signs include:
Kidney symptoms may progress quietly, making routine lab work especially important.
Amyloidosis can affect peripheral nerves, leading to:
Carpal tunnel syndrome appearing later in life—particularly when it affects both hands—can be an early clue.
Some women experience digestive system involvement, including:
These symptoms are often attributed to other gastrointestinal conditions, but persistent issues warrant further evaluation.
Less common but notable signs include:
While these signs are not always present, they can be important diagnostic clues.
One symptom alone may not raise concern. However, Amyloidosis often shows up as several small problems affecting different parts of the body at the same time. For example:
If you recognize this pattern, you can check your symptoms using a free AI-powered Amyloidosis symptom checker to help determine whether your concerns warrant a medical evaluation and to prepare for a more informed conversation with your doctor.
Amyloidosis is a progressive condition. Without treatment, organ damage can worsen over time. The good news is that medical understanding and treatment options have improved significantly in recent years.
Early diagnosis may:
Even when Amyloidosis cannot be cured, managing it earlier can make a real difference.
Diagnosis typically involves a combination of:
Because Amyloidosis is rare, diagnosis often requires referral to specialists such as cardiologists, nephrologists, or hematologists.
You don't need to assume the worst—but being informed is empowering.
Consider these practical steps:
If you're unsure how your symptoms fit together, using an AI-powered Amyloidosis symptom checker can help you organize your concerns and identify whether further medical evaluation may be appropriate.
Amyloidosis is uncommon, and many people with similar symptoms do not have it. Still, it is serious and often overlooked—especially in older women. Paying attention to your body and asking thoughtful questions is not overreacting; it's good healthcare.
If you or someone you care for has symptoms that could be serious or life-threatening—such as worsening shortness of breath, severe swelling, fainting, or rapid decline in health—speak to a doctor as soon as possible. Prompt medical evaluation is essential.
Amyloidosis may be rare, but awareness saves time, protects health, and supports better outcomes.
(References)
* Stone JR, Pahuja M, Ajithkumar A, Nattel M, Naim N, Sherif S, Dubin R, Bokhari S. Recognizing Transthyretin Amyloid Cardiomyopathy in Women: An Underdiagnosed and Underrepresented Population. J Card Fail. 2022 May;28(5):811-820. PMID: 34793910.
* D'Souza R, Dweck MR, Dungu JN, Dronamraju N, Garg P, Harkness A, Lachmann H, Lattimore G, Martinez-Naharro A, Whelan CJ, Wechalekar AD, Gillmore JD, Fontana M, Huttin O. Sex-Specific Differences in Clinical Presentation and Outcomes in Transthyretin Amyloid Cardiomyopathy. Circulation. 2021 May 11;143(19):1889-1899. PMID: 33596660.
* García-Pavía P, García-González C, García-Ortiz A, De Teresa E, Mazón P, Barrientos-Parejo N, Lara-Padrón A, de la Fuente-Fernández A, Ortiz-Fernández R, Martínez-Naharro A, De la Espriella R, Fontana M. Sex-related differences in amyloid cardiomyopathy due to transthyretin. Eur J Heart Fail. 2020 Dec;22(12):2249-2258. PMID: 32662283.
* D'Souza R, D'Souza S, Nordin S, Dungu JN. Prevalence of wild-type transthyretin amyloidosis in older patients with heart failure with preserved ejection fraction: a systematic review and meta-analysis. J Am Geriatr Soc. 2021 Jun;69(6):1604-1617. PMID: 33611728.
* Gertz MA. Amyloid light-chain amyloidosis: an update. Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):640-646. PMID: 34882046.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.